DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
JUSH logo

Jushi Holdings Inc. Stock Price

OTCPK:JUSH Community·US$120.2m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

JUSH Share Price Performance

US$0.61
-0.08 (-11.59%)
​
US$1.50
Fair Value
US$0.61
-0.08 (-11.59%)
59.3% undervalued intrinsic discount
US$1.50
Fair Value
Price US$0.61
AnalystConsensusTarget US$1.50
AnalystHighTarget US$2.00
AnalystLowTarget US$1.00
Wed, 12 Aug 26
Fair ValueUS$1.50
Share Pricen/a

JUSH Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$1.5 59.3% undervalued intrinsic discount

Pennsylvania And Virginia Reforms Will Unlock New Market Opportunities

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$2 69.5% undervalued intrinsic discount

Adult Use Legalization And Rescheduling Will Reshape Long Term Prospects For This Cannabis Operator

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$1 39.0% undervalued intrinsic discount

Rescheduling Uncertainty And Heavy Debt Will Pressure Cannabis Expansion Before Potential Upside

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
JUSH logo
Jushi Holdings
59.3% undervalued intrinsic discount

Pennsylvania And Virginia Reforms Will Unlock New Market Opportunities

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 12 Aug
Read Narrative
JUSH logo
Jushi Holdings
39.0% undervalued intrinsic discount

Rescheduling Uncertainty And Heavy Debt Will Pressure Cannabis Expansion Before Potential Upside

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Published 1 Jun
Read Narrative
JUSH logo
Jushi Holdings
69.5% undervalued intrinsic discount

Adult Use Legalization And Rescheduling Will Reshape Long Term Prospects For This Cannabis Operator

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 17 May
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
JUSH logo

JUSH: DEA Schedule III Registration Pathway Will Support Future Repricing

Fair Value: US$1.5 59.3% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
JUSH logo

Rescheduling Uncertainty And Heavy Debt Will Pressure Cannabis Expansion Before Potential Upside

Fair Value: US$1 39.0% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
JUSH logo

Adult Use Legalization And Rescheduling Will Reshape Long Term Prospects For This Cannabis Operator

Fair Value: US$2 69.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with low risk.

3 Risks
2 Rewards
View Full Analysis

Jushi Holdings Inc. Key Details

US$271.7m

Revenue

US$151.1m

Cost of Revenue

US$120.7m

Gross Profit

US$187.1m

Other Expenses

-US$66.4m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.33
44.41%
-24.44%
-162.2%
View Full Analysis

About JUSH

Founded
2018
Employees
1288
CEO
James Cacioppo
WebsiteView website
jushico.com

Jushi Holdings Inc. engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States. The company offers flower, vapes, concentrates, infused chews and chocolates, tinctures, capsules, softgels, topicals and RSO, pre-rolls, and infused chocolate bites under the Hijinks, The Bank, The Lab, Tasteology, Uncommon Kind, Nira + Medicinals, Sèche, Shayo, and Carm’s Delight Bites brands. It also engages in the sale of bulk raw materials to duly licensed third parties for use in its own finished products. In addition, the company operates medical cannabis dispensaries under the Beyond Hello, Nature’s Remedy, and NuLeaf brands. It serves small local dispensaries and large multi-state operators. Jushi Holdings Inc. was founded in 2018 and is headquartered in Boca Raton, Florida.

Recent JUSH News & Updates

User avatar
Narrative Update • Aug 12

JUSH: DEA Schedule III Registration Pathway Will Support Future Repricing

Analysts have raised their price target on Jushi Holdings to $1.50 from $1.00 after applying a slightly higher assumed future P/E multiple and making modest adjustments to their long-term revenue growth and profit margin expectations. What’s in the News for Jushi Holdings On June 24, 2026, Jushi Holdings shareholders approved a special resolution at the 2026 Annual General and Special Meeting to proceed with a plan of arrangement involving the continuance and domestication of the company from British Columbia, Canada, to the State of Nevada in the United States.
User avatar
Narrative Update • Jul 29

JUSH.F: DEA Schedule III Registrations And U.S. Domestication Will Support Rerating

Analysts have reduced their price target for Jushi Holdings to $1.00 from $1.50, citing updated assumptions that include a slightly higher discount rate, a modestly lower revenue growth outlook, improved profit margin expectations, and a lower future P/E multiple. What’s in the News for Jushi Holdings On June 24, 2026, Jushi Holdings shareholders approved a special resolution at the 2026 Annual General and Special Meeting to move forward with a plan of arrangement under Section 288 of the Business Corporations Act of British Columbia.

Recent updates

No updates

Jushi Holdings Inc. Competitors

SNDL logo

SNDL

Symbol: NasdaqCM:SNDL
Market cap: US$358.1m
CATX logo

Perspective Therapeutics

Symbol: NYSEAM:CATX
Market cap: US$356.2m
DMAC logo

DiaMedica Therapeutics

Symbol: NasdaqCM:DMAC
Market cap: US$352.7m
QTTB logo

Q32 Bio

Symbol: NasdaqCM:QTTB
Market cap: US$348.0m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide